First Wave BioPharma Announces Pricing of $2.1M Public Offering Of 3.285M Shares Of Its Common Stock For $0.64/Shares
Portfolio Pulse from Benzinga Newsdesk
First Wave BioPharma has announced the pricing of its public offering of 3.285 million shares of its common stock at $0.64 per share, aiming to raise $2.1 million.
July 19, 2023 | 12:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
First Wave BioPharma's public offering could dilute existing shares, potentially leading to a short-term decrease in stock price.
Public offerings often lead to share dilution, which can decrease the stock price in the short term as the market adjusts to the increased number of shares. However, the funds raised can be used for company growth, which may have positive long-term effects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100